Capital Southwest is rated Hold, offering an 11.0% distribution yield at a 1.40× NAV premium. While pre-tax net investment income (NII) covers the regular dividend, GAAP NII only covers 87.5% of the total distribution, raising questions about dividend sustainability. The company's net asset value (NAV) is supported by accretive share sales, but diluted NII per share is declining. Additionally, credit quality is weakening and leverage is increasing, suggesting caution. The analyst would consider buying shares if the price falls closer to $20.45 per NAV or if GAAP NII improves to $0.60 per share or better.
Capital Southwest, discussed in the recent analysis, is presented here with market context from Pluang's Financials sector. For readers following this sector, as of Nov 12, 2026 19:21 WIB, out of 142 priced US Financials stocks tradable on Pluang, 67 rose and 60 fell. Notable movers include Hut 8 Corp (HUT) at USD 58.00 with a 5.01% decline and a typical hold time of 12 days, Galaxy Digital Inc. Class A (GLXY) at USD 15.19 down 4.88% with 100% buy order activity, and Marathon Digital Holdings Inc (MARA) at USD 7.29 down 4.83% with 100% buy order activity.
Interlink Electronics announced a 3.4% revenue increase to $3.06 million for Q3 2026 and a 9.6% rise to $9.9 million for the first nine months of 2026, driven by higher shipments of force-sensing and gas-sensor products. The company reported a net lo...
ALS Canada, with renewed funding from TD Bank, is advancing its national strategy for ALS genetics to enhance access to genetic information, counselling, and care for Canadians affected by or at risk of ALS. This builds on the 2024 pilot of the first...
The Canadian ALS Society has renewed funding from TD Bank to expand its national genetics strategy for ALS, improving access to genetic information, counseling, and care for those affected or at risk. This initiative builds on a pilot project that cr...
CollPlant Biotechnologies will change its Nasdaq ticker from CLGN to OPHI starting November 13, 2026, reflecting its strategic shift toward photonic computing through its subsidiary LightSolver. This move highlights CollPlant's focus on developing Li...
Evaxion, a clinical-stage TechBio company, has released its financial calendar for 2027, outlining important dates for business updates and financial results. Key events include the full year 2026 results on March 4, the Annual General Meeting on Apr...
